Search Results 301-310 of 17175 for egfr

1. A Study to Evaluate Utilizing MRI for Earlier Diagnosis of Rheumatoid Arthritis - Mayo Clinic

   Contraindications to contrast-enhanced PCD-CT (eGFR < 30, history of previous contrast allergic reaction, history of premedication prior to iodinated contrast).

2. A Study to Evaluate Telisotuzumab Vedotin (ABBV-399) in Subjects with Previously Treated c-Met+ Non-Small Cell Lung Cancer - Mayo Clinic

   Subjects with histologically documented non-squamous NSCLC with known EGFR status (wild type or mutant; with site documented status). Of note, subjects with ...

3. To Evaluate The Long-term Safety And Tolerability Of Acoramidis In Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE) - Mayo Clinic

   Stage IV or V chronic kidney disease (corresponding to an eGFR ≤ 29 mL/min/1.73 m2), or undergoing renal dialysis, or recipient of a kidney transplant. 5 ...

4. A Study to Assess Imaging Tools for Patients Who Have Prostate Removal Surgery - Mayo Clinic

   eGFR should be above 30 within 30 days the time of mpMRI. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for ...

5. A Study to Evaluate the Safety, Tolerability, and Effectiveness of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis - Mayo Clinic

   Estimated glomerular filtration rate (eGFR) ≥ 30 milliliter/minute (mL/min), as calculated by the Cockcroft-Gault equation;; ALT ≤ 8 x upper limit of the ...

6. A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies - Mayo Clinic

   EGFR-positive or ALK-positive patients must have received at least one line of EGFR-directed or ALK-directed therapy, respectively; d. Must have received ...

7. A Study to Evaluate the Effectiveness of Nicotinamide Riboside and Pterostilbene Treatment to Protect the Kidneys in Patients with Complex Aortic Aneurysm Repair and Aortic Arch Reconstruction - Mayo Clinic

   Renal failure defined as eGFR< 15 mL/min/1.73m2. Patients in permanent Renal Replacement Therapy. Patients with chronic liver disease: Child-Pugh score ...

8. Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF - Mayo Clinic

   History of renal impairment as deemed clinically relevant by the investigator OR eGFR <60ml/min/1.73m2 within 60 days of Screening and a Screening eGFR of <60ml ...

9. A Study Of Tolododekin Alfa (ANK-101) In Combination With An Anti-PD-1/PD-L1 Antibody In Participants With Advanced Non-Small Cell Lung Cancer - Mayo Clinic

   Have known EGFR or ALK mutations. Have had prior treatment with recombinant interleukin-12 (IL-12). Have received short-term systemic therapy with ...

10. Electrocardiogram Clinical Trials - Mayo Clinic Research

    Ambulatory adult patients at increased risk for hyperkalemia due to age ≥ 50 years, and one or more criteria including eGFR (from serum creatinine) < 45 ...